The Future of Antibody–Drug Conjugates in Urothelial Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Future of Antibody–Drug Conjugates in Urothelial Cancer

Published:2023-05 Issue:1 Volume:3 Page:137-159
ISSN:2666-853X
Container-title:Advances in Oncology
language:en
Short-container-title:Advances in Oncology

Author:

Goodson David Alex,Friedlander Terence W.

Publisher

Elsevier BV

Reference115 articles.

1. Cancer statistics, 2022;Siegel;CA Cancer J Clin,2022

2. The effect of age and gender on bladder cancer: a critical review of the literature;Shariat;BJU Int,2010

3. Bladder cancer;Mushtaq;Surgery (Oxford),2019

4. Epidemiology of Bladder Cancer;Saginala;Med Sci (Basel),2020

5. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium;Shariat;J Urol,2006

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging molecular therapies in the treatment of bladder cancer;Exploration of Targeted Anti-tumor Therapy;2024-08-29

2. Activity of Enfortumab Vedotin and Sacituzumab Govitecan with Radiation in Preclinical Models of Bladder Cancer;European Urology;2024-07

3. Antibody-Drug Conjugates in Urothelial Cancer: From Scientific Rationale to Clinical Development;Cancers;2024-06-30

4. Antibody-drug conjugates in urinary tumors: clinical application, challenge, and perspectives;Frontiers in Oncology;2023-12-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP